Detalhe da pesquisa
1.
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy.
Ann Hematol
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38842564
2.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314897
3.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Br J Haematol
; 192(6): 978-987, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862447
4.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870594
5.
Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.
Hematol Oncol
; 39(3): 336-348, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33583077
6.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523289
7.
Cyanosis Due to Methemoglobinemia as the Presenting Sign of Glucose-6-Phosphate Dehydrogenase Deficiency in a Child: Diagnostic and Clinical Implications.
J Pediatr Hematol Oncol
; 43(8): e1140-e1144, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031164
8.
A Novel εγδß-Thalassemia Deletion Associated with Severe Anemia at Birth and a ß-Thalassemia Intermedia Phenotype Later in Life in Three Generations of a Greek Family.
Hemoglobin
; 45(6): 351-354, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31829079
9.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495951
10.
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Hematol Oncol
; 36(4): 693-700, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30129144
11.
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
Hematol Oncol
; 36(4): 645-650, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882363
12.
Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1671-1682, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756171
13.
Correction to: Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.
Ann Hematol
; 97(9): 1747, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29943159
14.
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Am J Hematol
; 93(7): 895-901, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29659040
15.
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.
Am J Hematol
; 98(5): E119-E122, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36808739
16.
Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.
Proc Natl Acad Sci U S A
; 112(10): E1106-15, 2015 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25713380
17.
Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Eur J Haematol
; 99(5): 409-414, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675766
18.
2017 Clinical trials update in new treatments of ß-thalassemia.
Am J Hematol
; 91(11): 1135-1145, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502996
19.
Polycomb group proteins and MYC: the cancer connection.
Cell Mol Life Sci
; 71(2): 257-69, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897499
20.
DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.
Cell Mol Life Sci
; 71(22): 4421-30, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25098353